Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Alzheimer's Disease

  Free Subscription


Articles published in JAMA Intern Med

Retrieve available abstracts of 11 articles:
HTML format



Single Articles


    October 2023
  1. BRENDER TD
    Chatbot Confabulations Are Not Hallucinations-Reply.
    JAMA Intern Med. 2023;183:1177-1178.
    PubMed    


    July 2023
  2. MOLCHAN S, Fugh-Berman A
    Are New Alzheimer Drugs Better Than Older Drugs?
    JAMA Intern Med. 2023 Jul 31. doi: 10.1001/jamainternmed.2023.3061.
    PubMed    


    June 2022
  3. WOLOSHIN S, Kesselheim AS
    What to Know About the Alzheimer Drug Aducanumab (Aduhelm).
    JAMA Intern Med. 2022 Jun 6. pii: 2792897. doi: 10.1001/jamainternmed.2022.1039.
    PubMed    


    March 2022
  4. PALAN LOPEZ R, Hendricksen M, McCarthy EP, Mazor KM, et al
    Association of Nursing Home Organizational Culture and Staff Perspectives With Variability in Advanced Dementia Care: The ADVANCE Study.
    JAMA Intern Med. 2022;182:313-323.
    PubMed     Abstract available


    February 2022
  5. LEE CS, Gibbons LE, Lee AY, Yanagihara RT, et al
    Association Between Cataract Extraction and Development of Dementia.
    JAMA Intern Med. 2022;182:134-141.
    PubMed     Abstract available


    December 2021
  6. LARGENT EA, Peterson A, Lynch HF
    FDA Drug Approval and the Ethics of Desperation.
    JAMA Intern Med. 2021;181:1555-1556.
    PubMed    


    October 2021
  7. CROSSON FJ, Covinsky K, Redberg RF
    Medicare and the Shocking US Food and Drug Administration Approval of Aducanumab: Crisis or Opportunity?
    JAMA Intern Med. 2021;181:1278-1280.
    PubMed    


    July 2021
  8. STEINBROOK R
    The Accelerated Approval of Aducanumab for Treatment of Patients With Alzheimer Disease.
    JAMA Intern Med. 2021 Jul 13. pii: 2782122. doi: 10.1001/jamainternmed.2021.4622
    PubMed    


  9. DUNN B, Stein P, Cavazzoni P
    Approval of Aducanumab for Alzheimer Disease-the FDA's Perspective.
    JAMA Intern Med. 2021 Jul 13. pii: 2782119. doi: 10.1001/jamainternmed.2021.4607
    PubMed    


  10. MITCHELL SL, D'Agata EMC, Hanson LC, Loizeau AJ, et al
    The Trial to Reduce Antimicrobial Use in Nursing Home Residents With Alzheimer Disease and Other Dementias (TRAIN-AD): A Cluster Randomized Clinical Trial.
    JAMA Intern Med. 2021 Jul 12. pii: 2782003. doi: 10.1001/jamainternmed.2021.3098
    PubMed     Abstract available


    November 2020
  11. NICHOLAS LH, Langa KM, Bynum JPW, Hsu JW, et al
    Financial Presentation of Alzheimer Disease and Related Dementias.
    JAMA Intern Med. 2020 Nov 30. pii: 2773241. doi: 10.1001/jamainternmed.2020.6432
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Alzheimer's Disease is free of charge.